NCT04431544

Brief Summary

AcQMap Registry is an observation study

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
513

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Typical duration for all trials

Geographic Reach
1 country

25 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 16, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

September 29, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2023

Completed
Last Updated

November 13, 2023

Status Verified

November 1, 2023

Enrollment Period

3.1 years

First QC Date

June 11, 2020

Last Update Submit

November 9, 2023

Conditions

Keywords

ablationatrial arrhythmia

Outcome Measures

Primary Outcomes (1)

  • Procedural Ablation Outcomes

    Number of participants who had termination of ablated arrhythmia's to Sinus Rhythm or another arrhythmia within 12 hours post ablation procedure with or without electrical or pharmacological cardioversion

    12 hours

Secondary Outcomes (1)

  • Long-term Outcome

    3 years

Interventions

To evaluate procedural and long-term outcomes when using the diagnostic AcQMap System as an imaging and mapping system for ablation of arrhythmias in accordance with the Instructions for Use (IFU).

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Any participant 18 years of age or older. Currently scheduled for an ablation of an arrhythmia utilizing the diagnostic AcQMap System.

You may qualify if:

  • Male or female 18 years of age or older. Currently scheduled for an ablation of an arrhythmia utilizing the diagnostic AcQMap System.
  • Willingness, ability and commitment to participate in baseline and follow-up evaluations for the full length of the study.
  • Willing and able to give written informed consent.

You may not qualify if:

  • In the opinion of the Investigator, any known contraindications to an ablation procedure.
  • Current enrollment in any study protocol sponsored by Acutus Medical. Any other condition that, in the judgment of the investigator, makes the participant a poor candidate for this procedure, the study, or compliance with the protocol (includes vulnerable patient population, mental illness, addictive disease, extensive travel away from the research center, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (25)

Grandview Medical Group Research

Birmingham, Alabama, 35243, United States

Location

Banner University Medical Institute

Phoenix, Arizona, 85006, United States

Location

St Jude Medical Center

Fullerton, California, 92835, United States

Location

University California San Diego

La Jolla, California, 92037, United States

Location

Keck School of Medicine of USC

Los Angeles, California, 90033, United States

Location

Mission Heritage Mission Viejo - Cardiac Electrophysiology

Mission Viejo, California, 92691, United States

Location

Eisenhower Medical Center

Rancho Mirage, California, 92270, United States

Location

Dignity Health Research Institute

Sacramento, California, 95819, United States

Location

Bethesda Hospital East

Boynton Beach, Florida, 33435, United States

Location

Clearwater Cardiovascular Consultants

Clearwater, Florida, 33756, United States

Location

Ascension St. Vincent's Medical Center Riverside

Jacksonville, Florida, 32204, United States

Location

Celebration Hospital

Orlando, Florida, 32803, United States

Location

Sarasota Memorial Research Institute

Sarasota, Florida, 34239, United States

Location

Bayfront (Orlando Health)

St. Petersburg, Florida, 33701, United States

Location

Saint Alphonsus Health System

Boise, Idaho, 83704, United States

Location

Kansas City Heart Rhythm Institute

Overland Park, Kansas, 66211, United States

Location

Baptist Lexington Medical Center

Lexington, Kentucky, 40503, United States

Location

Henry Ford Health Center

Detroit, Michigan, 48202, United States

Location

Nevada Heart and Vascular

Las Vegas, Nevada, 89118, United States

Location

Morristown Medical Center

Morristown, New Jersey, 07960, United States

Location

Weill Cornell Medicine, New York Presbyterian Hospital

New York, New York, 10021, United States

Location

ProMedica Physician Cardiology

Toledo, Ohio, 43606, United States

Location

Penn State Health Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033-0850, United States

Location

Texas Cardiac Arrhythmia Research Foundation

Austin, Texas, 78750, United States

Location

Methodist Healthcare

San Antonio, Texas, 78249, United States

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2020

First Posted

June 16, 2020

Study Start

September 29, 2020

Primary Completion

November 8, 2023

Study Completion

November 8, 2023

Last Updated

November 13, 2023

Record last verified: 2023-11

Locations